HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Barbara S Stonestreet Selected Research

inter-alpha-inhibitor

1/2022Inter-alpha Inhibitor Proteins Ameliorate Brain Injury and Improve Behavioral Outcomes in a Sex-Dependent Manner After Exposure to Neonatal Hypoxia Ischemia in Newborn and Young Adult Rats.
10/2021Changes in Cellular Localization of Inter-Alpha Inhibitor Proteins after Cerebral Ischemia in the Near-Term Ovine Fetus.
12/2020Effects of Juvenile or Adolescent Working Memory Experience and Inter-Alpha Inhibitor Protein Treatment after Neonatal Hypoxia-Ischemia.
12/2020Novel Neuroprotective Agents to Treat Neonatal Hypoxic-Ischemic Encephalopathy: Inter-Alpha Inhibitor Proteins.
12/2020Effects of inter-alpha inhibitor proteins on brain injury after exposure of neonatal rats to severe hypoxia-ischemia.
1/2020Pharmacokinetics of Inter-Alpha Inhibitor Proteins and Effects on Hemostasis After Hypoxic-Ischemic Brain Injury in Neonatal Rats.
1/2020Inter-alpha inhibitor proteins attenuate lipopolysaccharide-induced blood-brain barrier disruption and downregulate circulating interleukin 6 in mice.
5/2019Inter-alpha Inhibitor Proteins Modulate Neuroinflammatory Biomarkers After Hypoxia-Ischemia in Neonatal Rats.
1/2019Neuroprotective effects of inter-alpha inhibitor proteins after hypoxic-ischemic brain injury in neonatal rats.
4/2018Alterations in inter-alpha inhibitor protein expression after hypoxic-ischemic brain injury in neonatal rats.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Barbara S Stonestreet Research Topics

Disease

23Brain Injuries (Brain Injury)
04/2022 - 06/2002
18Ischemia
01/2022 - 06/2002
9Hypoxia (Hypoxemia)
04/2022 - 09/2015
7Brain Ischemia (Cerebral Ischemia)
10/2021 - 08/2003
3Sepsis (Septicemia)
01/2021 - 01/2018
3Inflammation (Inflammations)
01/2020 - 06/2014
3Infections
08/2017 - 01/2010
2Neuroinflammatory Diseases
01/2021 - 05/2019
2Hypothermia
01/2020 - 06/2018
2Gliosis
01/2018 - 04/2016
2Hemorrhage
09/2013 - 07/2007
2Hyperglycemia
05/2006 - 10/2004
2Premature Obstetric Labor (Premature Labor)
12/2005 - 08/2003
1Brain Edema (Cerebral Edema)
01/2022
1COVID-19
01/2021
1Ischemic Stroke
01/2021
1Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain)
12/2020
1Infarction (Infarctions)
12/2020
1Brain Diseases (Brain Disorder)
01/2020
1Stroke (Strokes)
01/2019
1Reperfusion Injury
01/2018
1Patent Ductus Arteriosus
09/2016
1Neurologic Manifestations (Neurological Manifestations)
04/2016
1Premature Birth (Birth, Premature)
11/2014
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
03/2014
1Birth Weight (Birth Weights)
09/2013
1Hyperinsulinism (Hyperinsulinemia)
05/2006
1Insulin Resistance
05/2006
1Bronchopulmonary Dysplasia
01/2006
1Fetal Weight
11/2002

Drug/Important Bio-Agent (IBA)

26Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2006
15inter-alpha-inhibitorIBA
01/2022 - 06/2014
12CytokinesIBA
01/2021 - 01/2010
6salicylhydroxamic acid (SHAM)IBA
04/2022 - 06/2014
4Adrenal Cortex Hormones (Corticosteroids)IBA
07/2007 - 08/2003
3Neuroprotective AgentsIBA
01/2022 - 01/2019
3HMGB1 Protein (HMG1)IBA
01/2021 - 01/2016
3Monoclonal AntibodiesIBA
06/2018 - 01/2015
3Tight Junction ProteinsIBA
05/2015 - 07/2007
3Interleukin-6 (Interleukin 6)IBA
05/2015 - 01/2010
2PlacebosIBA
04/2022 - 06/2002
2Blood Proteins (Serum Proteins)IBA
01/2021 - 08/2017
2LipidsIBA
01/2020 - 07/2019
2Glial Fibrillary Acidic ProteinIBA
05/2019 - 01/2018
2Oxygen (Dioxygen)IBA
01/2019 - 08/2003
2Nuclear Proteins (Protein, Nuclear)IBA
01/2019 - 01/2016
2Neutralizing AntibodiesIBA
01/2018 - 05/2015
2AntibodiesIBA
01/2017 - 01/2015
2Indomethacin (Indometacin)FDA LinkGeneric
09/2016 - 09/2013
2GlucocorticoidsIBA
04/2016 - 03/2014
2Glucose (Dextrose)FDA LinkGeneric
05/2006 - 10/2004
2SteroidsIBA
12/2005 - 08/2003
2Dexamethasone (Maxidex)FDA LinkGeneric
08/2003 - 11/2002
1Claudin-5IBA
04/2022
1cresyl violetIBA
01/2022
1Histones (Histone)IBA
01/2021
1LipopolysaccharidesIBA
01/2020
1ErythropoietinFDA Link
01/2020
1Metformin (Glucophage)FDA LinkGeneric
01/2020
1Biomarkers (Surrogate Marker)IBA
05/2019
1Peroxidase (Myeloperoxidase)IBA
05/2019
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
05/2019
1CalciumIBA
05/2019
1Indicators and Reagents (Reagents)IBA
01/2019
1Myelin Basic ProteinIBA
01/2018
1fluoro jadeIBA
01/2018
1progelatinaseIBA
01/2018
1Tissue Inhibitor of Metalloproteinase-1IBA
01/2018
1Matrix Metalloproteinases (MMPs)IBA
01/2018
1Metalloproteases (Metalloproteinases)IBA
01/2018
1Caspase 3 (Caspase-3)IBA
01/2018
1pre-alpha-trypsin inhibitorIBA
01/2017
1Pharmaceutical PreparationsIBA
09/2013
1InterleukinsIBA
01/2010
1Hydrocortisone (Cortisol)FDA LinkGeneric
05/2006
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
06/2002

Therapy/Procedure

4Therapeutics
01/2020 - 03/2014
2Ligation
04/2022 - 01/2019
2Treatment Delay
12/2020 - 01/2019
1Induced Hypothermia
01/2020
1Intravenous Infusions
01/2018